Medical devices, healthcare technology and the business of care
FDA RECALL RECORD · Z-1482-2026

Brand Name: B. Braun Product Name: 21GA WINGED INFUSION, SINGLE PK Recall

Brand Name: B. Braun Product Name: 21GA WINGED INFUSION, SINGLE PK Model/Catalog Number: 7A3842 Software Version: N/A Product Description: A device designed for subcutaneous implantation and intended to be used temporarily to expand an implanted tissue expander by percutaneous injection of air or fluids. Component: N/A

FDA recall Class II

Ongoing

FDA lists this Class II recall for Brand Name: B. Braun Product Name: 21GA WINGED INFUSION, SINGLE PK. Review the affected identifiers, reported reason and manufacturer instructions below.

Recall at a glance

Recall number
Z-1482-2026
Recall classification
Class II
Enforcement status
Ongoing
Initiation date
Feb 2, 2026
FDA report date
Mar 11, 2026
Quantity in commerce
21000 units
Distribution
See key details
FDA cause
Process control

What is being recalled?

Brand Name: B. Braun Product Name: 21GA WINGED INFUSION, SINGLE PK Model/Catalog Number: 7A3842 Software Version: N/A Product Description: A device designed for subcutaneous implantation and intended to be used temporarily to expand an implanted tissue expander by percutaneous injection of air or fluids. Component: N/A

Affected model & UDI checker

Search the exact identifiers published for Z-1482-2026.

The lookup covers structured identifiers listed on this page. A full UDI may also contain lot or serial information; a GTIN match alone does not check those conditions.

Affected products

Model / catalog numberProductLot scope reportedUDI / GTIN
7A3842Brand Name: B. Braun Product Name: 21GA WINGED INFUSION, SINGLE PKCheck source noticeNot specified
FDA code information

Model/Catalog Number: 7A3842; Primary-DI 4046964338434; Unit of Use- DI 4046964338410; Lot 0062004706, Exp 31MAR2032; Lot 0062005799, Exp 30JUN2032; Lot 0062006415, Exp 31MAR2032; Lot 0062006416, Exp 31MAR2032; Lot 0062023397, Exp 30JUN2032; Lot 0062024887, Exp 31JUL2032

View the original FDA recall notice

Why was this product recalled?

The potential for the needle tip to be dull/blunt, difficult to advance, and/or break.

These are potential consequences described in the source. The recall reason does not establish how many injuries or incidents occurred.

What actions did B. BRAUN MEDICAL INC. take?

On February 2, 2026 URGENT MEDICAL DEVICE RECALL NOTIFICATION letters were sent to customers. Actions to be taken: 1. Review the notice in its entirety and ensure that all users in your organization are aware and informed about this voluntary recall. If you are a distributor and have further distributed the product, please forward this notice to your consignees. The recall is to be extended to the hospital/healthcare facility level. 2. Examine inventory for affected product, cease use and quarantine product subject to recall. Do not destroy any affected product. 5. Once we receive your Acknowledgement Form, a B. Braun Customer Support representative will contact you with instructions on how to return any impacted cases, including partial cases, in your possession and provide credit and/or replacement of the product based on your individual needs.

Read the manufacturer action recorded by FDA

Recall timeline

  1. Recall initiated by firm

  2. FDA notice posted

  3. FDA classification recorded

  4. FDA enforcement report date

Related FDA submissions

No submission number with an exact verified relationship is linked in the retrieved recall notice.

FDA’s notice explicitly links the submission numbers shown here. Read each filing for its own recorded device and scope.

Source and update history

  1. FDA enforcement data

    First stored snapshot of this source.

  2. FDA device-recall notice

    First stored snapshot of this source.

The history starts with the versions held by MedtechLedger. Earlier source changes are not reconstructed. Official dates and recorded status come from FDA; page summaries describe the source information.

Our data sources and methodology